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Objective: A controversial issue is whether self-report of symptoms and impairment is sufﬁcient for
diagnosis of attention-deﬁcit/hyperactivity disorder (ADHD) in adolescents and adults in the absence of
other informants, such as parents. The present study investigated how well self-report is reﬂected by
cognitive-neurophysiological and actigraph measures, which we have previously shown to discriminate
between ADHD persisters, remitters and controls using parent-report (Cheung et al., 2015; Brit J Psychiat
http://dx.doi.org/10.1192/bjp.bp.114.145185).
Method: Parent- and self-reported ADHD symptoms and impairment, together with cognitive, electro-
encephalogram (EEG) frequency, event-related potential (ERP) and actigraph measures were obtained
from 108 adolescents and young adults with childhood ADHD and 167 controls.
Results: Participants reported lower levels of ADHD symptoms and impairments than parents (p < 0.05)
and the ADHD persistence rate based on self-report was low at 44%, compared to the persistence rate of
79% previously reported based on parent-report. Regression analyses showed that the objective mea-
sures distinguished poorly between ADHD persistent and remittent groups based on self-report, in
contrast to ﬁndings based on parent-report (Cheung et al., 2015), although the measures differentiated
well between ADHD persisters and controls. Correlation analyses revealed that self-reported impairment
signiﬁcantly correlated with fewer of the objective measures, despite parent- and self-reported symp-
toms showing similar correlations with the measures.
Conclusions: The ﬁndings show that self-reported ADHD outcome is not as well reﬂected by cognitive-
neurophysiological and movement correlates as we previously found for parent-reported ADHD.
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Attention-deﬁcit/hyperactivity disorder (ADHD) is a childhood-Rietz), celeste.cheung@kcl.ac.
(G. McLoughlin), brandeis@
aschewski@zi-mannheim.de
rson), jonna.kuntsi@kcl.ac.uk
ier Ltd. This is an open access articonset neurodevelopmental disorder that frequently has long-term
impact throughout the lifespan (National Institute of Health and
Clinical Excellence; NICE, 2008). Childhood ADHD has an esti-
mated prevalence of around 5.3% (95% CI: 5.01e5.56) world-wide
(Polanczyk et al., 2007), and often persists into adulthood where
the prevalence rate is 2.5% (95% CI: 2.1e3.1) (Simon et al., 2009).
While parents and teachers are used as main sources for estab-
lishing diagnoses in children, self-report becomes increasingly
important during diagnostic interviews in adolescence and young
adulthood. There is, however, scarcity of research evaluating thele under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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diagnosis of ADHD in adolescents and young adults.
Previous research suggests modest agreement between self-
and parent-ratings of ADHD symptoms in adolescents and young
adults (r ¼ 0.16e0.30) (Barkley et al., 2002; Pierrehumbert et al.,
2006; Wan Salwina, 2013). Young individuals tend to report their
ADHD symptoms as less severe than their parents, which results in
lower rates of ADHD persistence into adulthood based on self-
report (Barkley et al., 2002; Kooij et al., 2008; Pierrehumbert
et al., 2006). This suggests that follow-up studies that rely on
self-report may estimate persistence of ADHD to be lower than
studies using parent-report (Barkley et al., 2002; Wolraich et al.,
2005). The exclusive reliance on adult self-report may have in
part contributed to the low ADHD persistence rate of 5% recently
reported by Mofﬁtt et al. (2015), which is substantially lower than
previous follow-up studies that have relied on both self- and
parent-report and reported persistence rates between 15% and 35%
(Biederman et al., 2010; Faraone et al., 2006). This discrepancy
could also be explained by differences between population and
clinical samples.
Overall, existing research is limited, yet suggestive evidence is
emerging that self-report of ADHD may have lower validity than
parent-report. Population-based and clinical ADHD studies have
found that self-reported ADHD symptoms show weaker associa-
tions with poor school achievement in adolescence (Pierrehumbert
et al., 2006) andmajor life events in young adulthood (Barkley et al.,
2002), compared to parent-report. Furthermore, the estimated
heritability of adolescent and adult ADHD based on self-reported
symptoms (38e48%) (Larsson et al., 2013; Merwood et al., 2013)
is lower than heritability estimates based on parent-reported
symptoms (64e82%) (Cheung et al., 2015; Merwood et al., 2013),
and clinically-diagnosed ADHD (88%) (Larsson et al., 2014), as
deﬁned by taking ADHDmedication. The low heritability estimates
for self-reported ADHD could be attributed to rater-bias effects
introduced by using self-report, but is also likely due to the use of
different informants to rate each twin in a pair rather than relying
on a single informant (Brikell et al., 2015; Merwood et al., 2013).
While studies converge in suggesting that self-report of ADHD
shows lower validity than parent-report, no studies have compared
the validity of source informants using cognitive-
neurophysiological and movement correlates of ADHD. Objective
measures could be used to examine how well each informant
report of ADHD is reﬂected by cognitive-neurophysiological and
movement data.
We previously reported ﬁndings from a prospective study that
successfully discriminated between ADHD persistent, remittent
and control groups on cognitive-electrophysiological and actigraph
measures (Cheung et al., 2015). The ADHD groups were based on
parent-reports, given the relatively young age range of the sample
(11e25 years), as literature suggests children with ADHD may be
poor at judging their own problematic behavior (Hoza et al., 2002,
2004). Preparation-vigilance processes (omission errors (OE), re-
action time variability (RTV), contingent negative variation (CNV),
delta activity), as well as IQ and actigraph count, were markers of
remission in early adulthood. These processes distinguished be-
tween ADHD persisters and remitters, but not between ADHD re-
mitters and controls.
We now examine ADHD persistence and remittance based on
self-report in young adulthood using the same sample as our pre-
vious study (Cheung et al., 2015). The aim is to gain a better un-
derstanding of discrepancies between self- and parent-report and
to investigate how well self-report is reﬂected by ADHD sympto-
mology at the level of cognition, neurophysiology and movement.
Given how ADHD is deﬁned, we can examine inattentive, hyper-
active and impulsive symptoms at an objective level of attentionprocesses and ﬁdgeting, although it is important to acknowledge
that these are not regarded as gold-standard objective measures in
the diagnostic process of ADHD and are limited to laboratory
settings.
The main aims of the present study are to examine (i) whether
self- and parent-report of ADHD differ in severity; (ii) howwell the
objective data discriminate between ADHD persisters, remitters
and controls based on self-report of ADHD using DSM-IV criteria
and (iii) the pattern of correlations between self-reported ADHD
symptoms and impairments and the objective data.
Based on DSM-IV (The Diagnostic and Statistical Manual of
Mental Disorders, 4th ed.), individuals are diagnosed with ADHD if
they display at least six symptoms in either the inattentive or
hyperactive-impulsive domains, and experience symptoms and
impairment in at least two settings. In the revised DSM-5 criteria,
individuals aged 17 or older only require the presence of ﬁve
symptoms and the presence of symptoms in at least two settings,
rather than impairments from symptoms in two settings. Thus, we
run additional analyses to investigate whether the objective data
discriminate better between ADHD groups, based on self-report,
using the revised DSM-5 criteria of displaying at least 5 ADHD
symptoms.2. Method
2.1. Participants
The sample consists of 275 participants, followed-up on average
5.8 years (SD ¼ 1.1) after initial assessments. At follow-up, partic-
ipants were on average 18.0 years of age (age range: 11.1e25.9). 17
individuals were between 11 and 13 years, 79 individuals were
between 14 and 16 years, 116 individuals were between 17 and 19
years and 63 individuals were 20 years and older. 108 participants
had a diagnosis of DSM-IV combined type ADHD in childhood (9
sibling pairs, 90 singletons) and 167 were controls (74 sibling pairs,
19 singletons).
Participants with ADHD were initially recruited from ADHD
clinics in south-east England (Kuntsi et al., 2010). Diagnosis of DSM-
IV combined type ADHD was established using the Parental Ac-
count of Childhood symptoms (PACS), a semi-structured interview
with high inter-rater reliability (Chen et al., 2008). Controls were
recruited from schools in the same region and were age and sex
matched with the clinical sample. All participants were aged be-
tween 6 and 17 at initial assessment. Exclusion criteria were:
IQ < 70, autism, epilepsy, general learning difﬁculties, brain disor-
ders and any genetic or medical disorder associated with exter-
nalizing behaviors that might mimic ADHD. The investigation was
carried out in accordance with the latest version of the Declaration
of Helsinki. The study design was reviewed by an appropriate
ethical committee and informed consent of participants was ob-
tained after the nature of the procedures had been fully explained.
At follow up, eight controls met ADHD criteria based on self-
(n ¼ 2) or parent- (n ¼ 6) ratings on the Barkley Informant Rating
Scale, and eight participants had missing self- or parent-ratings of
impairments. These participants were excluded from analyses.2.2. Procedure
Participants were scheduled for a follow-up clinical interview
and cognitive-electroencephalogram (EEG) assessments at the
research center where initial assessments took place. A 48-h ADHD
medication-free period was required. The total length of the test
session, including breaks, was approximately 4 h.
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The Diagnostic Interview for ADHD in adults (DIVA) is a semi-
structured interview evaluating the DSM-IV criteria for adult and
childhood ADHD symptoms and impairment (Kooij and Francken,
2007). The DIVA was conducted by trained researchers with par-
ticipants and parents separately.
The Barkley's functional impairment scale (BFIS) (Barkley and
Murphy, 2006). This 10-item scale assesses levels of functional
impairments associatedwith ADHD symptoms in ﬁve areas: family/
relationship; work/education; social interaction; leisure activities
and management of daily responsibilities. Each item ranged from
0 (never or rarely) to 3 (very often). Participants and parents both
completed the questionnaire.
Participants were classiﬁed as ADHD persistent at follow-up
based on DSM-IV criteria; if they scored ‘yes’ on  6 items in
either the inattention or hyperactivity-impulsivity domains, and if
they scored 2 on two or more areas of impairments.
Barkley Informant Rating Scale (Barkley and Murphy, 2006). This
rating scale (based on DSM-IV items) was used to identify controls
meeting ADHD diagnostic criteria at follow up. Each item ranged
from 0 (never or rarely) to 3 (very often). Participants and parents
both completed the questionnaire.
IQ and digit span. The vocabulary and block design subtests of
the Wechsler Abbreviated Scale of Intelligence (WASI) were
administered to derive an IQ estimate (Wechsler, 1999). The digit
span subtest from the WISC-III (Wechsler, 1991) or the WAIS-III
(Wechsler, 1997) was administered to participants aged below
16 and aged 16 or above, respectively, to obtain digit span forward
(DSF) and backward (DSB). DSF requires participants to verbally
repeat a sequence of digits in straightforward order, and mea-
sures short-term verbal memory. DSB requires participants to
repeat digits in backward order, and measures verbal working
memory.
Actigraph measures of activity level. Actigraph readings were
taken during interviews and assessments. We previously showed
that mean intensity and mean number of movements, obtained
from the dominant ankle, reliably distinguished between ADHD
probands and controls (ROC-AUC ¼ 0.61e0.79) (Wood et al., 2009).
The Fast Task (Andreou et al., 2007). The baseline condition
consists of 72 trials, which followed a standard warned four-choice
RT task. Four empty circles (warning signals, arranged horizontally)
ﬁrst appeared for 8s, after which one of them (the target) was
colored in. Participants were asked to press the response key cor-
responding to the target position. Following responses, the stimuli
disappeared and a ﬁxed inter-trial interval of 2.5s followed. Speed
and accuracy were emphasized equally. If participants did not
respond within 10s, the trial terminated. A comparison condition
with a fast event rate (1s) and incentives followed the baseline
condition. We used the RTV from the baseline condition, as this
condition is more sensitive to ADHD (Kuntsi et al., 2013).
The cued ﬂanker Continuous Performance Task (CPT-OX)
(Doehnert et al., 2008; Valko et al., 2009). This CPT includes rare
cued Go and NoGo conditions embedded in a vigilance task with
frequent distractors to assess attention and inhibition. 400 letters
are presented for 150 ms with a stimulus onset asynchrony of
1.65 s in a pseudo-randomized order. The cue letter O occurred
with 20% probability (80 Cue stimuli), signaling a GoeNoGo task.
Participants pressed a button as fast as possible every time the cue
was followed directly by the letter X (O-X) target sequence (10%
probability, 40 Go stimuli), but had to withhold responses to O-
not-X sequences (NoGo trials, also 10%, 40 NoGo stimuli). RTV,
commission errors (CE), OE; EEG frequency bands; and event-
related potential (ERP) amplitude measures of CNV, cue-P3 and
nogo-P3 were obtained.2.4. EEG recording and processing
EEG was recorded from 62 channels DC-coupled recording
system (extended 10e20 montage), with a 500 Hz sampling-rate,
impedances kept under 10 kU and FCz as the reference electrode.
The electro-oculograms (EOGs) were recorded from electrodes
above and below the left eye and at the outer canthi.
The EEG data were analyzed using Brain Vision Analyzer (2.0)
(Brain Products, Munich, Germany). After down-sampling the data
to 256 Hz, the EEG data were re-referenced to the average and
ﬁltered ofﬂine with digitally band-pass (0.1e30 Hz, 24 dB/oct)
Butterworth ﬁlters. Ocular artifacts were identiﬁed using Inde-
pendent Component Analysis (ICA) (Jung et al., 2000). The extrac-
ted components were manually inspected and ocular artifacts were
removed by back-projection of all but those components. Datawith
other artifacts exceeding ±100 mV in any channel were rejected. No
baseline subtractionwas applied in line with previous ERP analyses
on this task (Doehnert et al., 2013; McLoughlin et al., 2011). All
averages contained at least 20 sweeps.
2.5. ERP analyses
The CNVs were analyzed as mean amplitudes 1300e1650ms
following cues over the central electrode (Cz). The cue-P3 had a
parietal maximum and was deﬁned as the most positive peak
250e600ms following cue trials at electrode Pz. The nogo-P3 was
deﬁned as the most positive peak 250e600ms following no-go
trials at electrode Cz.
2.6. EEG frequency analyses
We estimated mean EEG power (mV2) by computing the mean
activity of electrodes (F1eF8, Fz) in the delta (0.5e3 Hz), theta
(4e7 Hz), alpha (7e12 Hz) and beta (12e30 Hz) bands using the
Fast Fourier Transform (FFT). We analyzed the frontal location only,
to be consistent with our previous analyses (Cheung et al., 2015).
2.7. Statistical analyses
We ran regression models with dummy variables to identify
which measures showed an effect of group (ADHD persisters vs
ADHD remitters vs controls), with controls as the reference group.
Post-hoc t-tests were conducted to examine ADHD persistent-
remittent differences. We explored the effect of sex by re-running
analyses with females (n ¼ 55) removed. We also re-ran the ana-
lyses using groups based on DSM-5 criteria of having ﬁve, rather
than six, ADHD symptoms. Cohen's d effect sizes are presentedwith
means, SDs and test statistics for the group analyses; 0.2 is
considered a small effect, 0.5 a medium effect and 0.8 a large effect.
Pearson correlations were conducted on the objective measures
to examine their associations with DIVA ADHD symptom scores
and clinical impairment, within those with childhood ADHD, with
age and gender included as covariates.
We ran additional analyses to investigate whether the combi-
nation of information from self- and parent-reports is better re-
ﬂected by the objective measures compared to only using parent-
report. We compared proﬁles of individuals with both self- and
parent-reported ADHD (concordant group), individuals with only
parent-reported ADHD (discordant group) and controls on the
objective measures and reports of impairment. We did not examine
individuals with only self-reported ADHD as this group of in-
dividuals was too small (n ¼ 17).
We re-ran all analyses covarying for IQ to examine its potential
effects. All cognitive and EEG measures were skewed and log-
transformed to normal in STATA version 10 (StataCorp, College
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controlled for by using the ‘robust cluster’ command in STATA.
3. Results
Based on self-reports of symptoms and impairment, 44% of in-
dividuals with childhood ADHD continued tomeet DSM-IV levels of
ADHD and were classiﬁed as ADHD persisters. As reportedTable 1
Comparisons on age, sex, IQ, digit span, cognitive, event-related potential (ERP), electroe
report.
ADHD persisters
(n ¼ 48)
ADHD remitters
(n ¼ 60)
Controls
(n ¼ 167)
Mean age (SD) 18.54 (2.89) 18.34 (3.19) 17.77 (2.20)
Male n (%) 39 (81%) 54 (90%) 127 (76%)
Cognitive measures
IQ 98.25 (17.06) 97.20 (13.86) 110.23 (12.15)
Digit span forward 9.60 (2.45) 9.38 (1.74) 10.46 (2.15)
Digit span backward 6.17 (2.37) 6.62 (2.42) 8.04 (2.61)
RTV (CPT-OX) 99.55 (51.97) 107.00 (60.77) 79.05 (36.96)
RTV (Fast Task) 4.77 (0.77) 4.37 (0.86) 3.76 (0.89)
CE (CPT-OX) 1.96 (2.44) 1.98 (2.37) 0.86 (1.33)
OE (CPT-OX) 2.79 (3.76) 2.01 (3.78) 0.60 (1.00)
ERPs (CPT-OX)
CNV 2.76 (1.80) 3.21 (1.83) 3.84 (1.86)
Cue P3 6.51 (0.50) 6.71 (0.56) 6.81 (0.44)
No-go P3 7.00 (0.46) 7.06 (0.36) 7.17 (0.38)
EEG frequency bands (CPT-OX)
Delta 1.54 (0.49) 1.58 (0.54) 1.45 (0.43)
Theta 0.15 (0.53) 0.15 (0.55) 0.25 (0.51)
Alpha 0.35 (0.62) 0.41 (0.72) 0.59 (0.61)
Beta 1.65 (0.69) 1.63 (0.54) 1.80 (0.57)
Actigraph movement
Mean intensity 1.20 (0.74) 1.03 (0.69) 0.77 (0.55)
Mean count 0.05 (0.04) 0.04 (0.04) 0.03 (0.06)
RTV, reaction time variability; CE, commission errors; OE, omission errors; CNV, continuou
signiﬁcant.
a ADHD persisters vs controls.
b ADHD persisters vs ADHD remitters.
c ADHD remitters vs controls.previously (Cheung et al., 2015), 79% of individuals were classiﬁed
as ADHD persisters based on parent-report. Using DSM-5 symptom
criteria, 47% of individuals were classiﬁed as ADHD persisters based
on self-report, while the persistence rate remained the same for
parent-report.
At follow up, based on self-report, ADHD persisters, remitters
and controls did not differ in age, but there were signiﬁcantly more
males in the remitted group than the control group (Table 1). Thencephalogram (EEG) and actigraph measures between ADHD groups based on self-
F df p Cohen's dʹ Cohen's dʹ (IQ controlled)
1.94 2, 191 0.15
4.07 2, 191 0.02
21.76 2, 191 <0.01 a ¼ 0.58**
b ¼ 0.07
c ¼ 0.80**
7.46 2, 190 <0.01 a ¼ 0.31*
b ¼ 0.10
c ¼ 0.51**
a ¼ 0.09
b ¼ 0.06
c ¼ 0.17
12.34 2, 190 <0.01 a ¼ 0.61**
b ¼ 0.19
c ¼ 0.51**
a ¼ 0.38*
b ¼ 0.27
c ¼ 0.16
5.82 2, 190 <0.01 a ¼ 0.34*
b ¼ 0.07
c ¼ 0.39**
a ¼ 0.21
b ¼ 0.05
c ¼ 0.26
28.67 2, 191 <0.01 a ¼ 0.99**
b ¼ 0.50**
c ¼ 0.59**
a ¼ 0.80**
b ¼ 0.58**
c ¼ 0.36**
10.04 2, 190 <0.01 a ¼ 0.40**
b ¼ 0.06
c ¼ 0.52**
a ¼ 0.29*
b ¼ 0.04
c ¼ 0.32*
14.00 2, 189 <0.01 a ¼ 0.61**
b ¼ 0.34
c ¼ 0.44**
a ¼ 0.52**
b ¼ 0.38
c ¼ 0.22
6.75 2, 187 <0.01 a ¼ 0.47**
b ¼ 0.25
c ¼ 0.28*
a ¼ 0.43**
b ¼ 0.25
c ¼ 0.21
6.86 2, 187 <0.01 a ¼ 0.50**
b ¼ 0.38
c ¼ 0.19
a ¼ 0.51**
b ¼ 0.38
c ¼ 0.18
3.33 2, 179 0.04 a ¼ 0.30*
b ¼ 0.13
c ¼ 0.26
a ¼ 0.23
b ¼ 0.13
c ¼ 0.16
1.58 2, 188 0.21 a ¼ 0.16
b ¼ 0.08
c ¼ 0.22
a ¼ 0.03
b ¼ 0.07
c ¼ 0.03
1.60 2, 188 0.20 a ¼ 0.19
b ¼ 0.08
c ¼ 0.20
a ¼ 0.03
b ¼ 0.01
c ¼ 0.03
3.43 2, 189 0.03 a ¼ 0.33*
b ¼ 0.10
c ¼ 0.22
a ¼ 0.26
b ¼ 0.10
c ¼ 0.16
2.24 2, 189 0.11 a ¼ 0.18
b ¼ 0.04
c ¼ 0.27
a ¼ 0.10
b ¼ 0.03
c ¼ 0.15
7.83 2, 168 <0.01 a ¼ 0.54**
b ¼ 0.25
c ¼ 0.34*
a ¼ 0.45**
b ¼ 0.26
c ¼ 0.25
5.82 2, 141 <0.01 a ¼ 0.42**
b ¼ 0.26
c ¼ 0.27
a ¼ 0.33*
b ¼ 0.25
c ¼ 0.19
s negative variation *p-value < 0.05, ** p-value < 0.01. P-values presented in bold are
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tent and remittent groups (z ¼ 0.31, p ¼ 0.76).
Almost half (47%) of the participants were under medication
treatment for ADHD at the time of the follow-up assessment. The
proportion of participants on medication at follow up did not differ
between persistent and remittent groups based on either self-
report (c ¼ 1.46, p ¼ 0.23) or parent-report (c ¼ 1.95, p ¼ 0.16).Table 2
Comparisons on age, sex, IQ, digit span, cognitive, event-related potential (ERP), electroe
report using DSM-5 criteria.
ADHD persisters
(n ¼ 51)
ADHD remitters
(n ¼ 57)
Co
(n
Mean age (SD) 18.55 (2.81) 18.32 (3.27) 17
Male n (%) 42 (82%) 51 (89%) 12
Cognitive measures
IQ 98.29 (16.58) 97.11 (14.18) 11
Digit span forward 9.64 (2.39) 9.33 (1.76) 10
Digit span backward 6.18 (2.31) 6.63 (2.45) 8.0
RTV (CPT-OX) 96.62 (51.76) 109.96 (60.88) 79
RTV (Fast Task) 4.78 (0.89) 4.39 (0.86) 3.7
CE (CPT-OX) 1.86 (2.63) 2.07 (2.40) 0.8
OE (CPT-OX) 2.60 (3.72) 2.11 (3.86) 0.6
ERPs (CPT-OX)
CNV 2.90 (1.91) 3.11 (1.74) 3
Cue P3 6.55 (0.51) 6.69 (0.56) 6.8
No-go P3 7.00 (0.50) 6.99 (0.45) 7.1
EEG frequency bands (CPT-OX)
Delta 1.54 (0.54) 1.61 (0.54) 1.4
Theta 0.17 (0.53) 0.09 (0.61) 0
Alpha 0.37 (0.61) 0.40 (0.73) 0
Beta 1.68 (0.68) 1.60 (0.54) 1
Actigraph movement
Mean intensity 1.15 (0.75) 1.06 (0.68) 0.7
Mean count 0.05 (0.04) 0.04 (0.04) 0.0
RTV, reaction time variability; CE, commission errors; OE, omission errors; CNV, continuo
are signiﬁcant.
a ADHD persisters vs controls.
b ADHD persisters vs ADHD remitters.
c ADHD remitters vs controls.3.1. Do self-reports of ADHD symptoms and impairments differ in
severity from parent-reports in individuals with a childhood
diagnosis of ADHD?
The average number of self-reported inattentive symptoms
(M ¼ 5.82, SD ¼ 0.23) was signiﬁcantly lower (t (107) ¼ 6.85,
p < 0.001) than the number of parent-reported symptomsncephalogram (EEG) and actigraph measure between ADHD groups based on self-
ntrols
¼ 167)
F df p Cohen's dʹ
.77 (2.20) 2.03 2, 191 0.13
7 (76%) 3.59 2, 191 0.03
0.23 (12.15) 21.41 2, 191 <0.01 a ¼ 0.61**
b ¼ 0.08
c ¼ 0.79**
.46 (2.15) 7.72 2, 190 <0.01 a ¼ 0.30*
b ¼ 0.15
c ¼ 0.51**
4 (2.61) 12.50 2, 190 <0.01 a ¼ 0.62**
b ¼ 0.19
c ¼ 0.48**
.05 (36.96) 6.08 2, 190 <0.01 a ¼ 0.29*
b ¼ 0.19
c ¼ 0.43**
6 (0.89) 26.43 2, 191 <0.01 a ¼ 0.94**
b ¼ 0.40*
c ¼ 0.59**
6 (1.33) 10.33 2, 190 <0.01 a ¼ 0.37**
b ¼ 0.15
c ¼ 0.54**
0 (1.00) 13.59 2, 189 <0.01 a ¼ 0.60**
b ¼ 0.26
c ¼ 0.45**
.84 (1.86) 5.92 2, 187 <0.01 a ¼ 0.40**
b ¼ 0.11
c ¼ 0.33*
1 (0.44) 6.36 2, 187 <0.01 a ¼ 0.45**
b ¼ 0.22
c ¼ 0.26
7 (0.38) 3.33 2, 179 0.04 a ¼ 0.26
b ¼ 0.03
c ¼ 0.29*
5 (0.43) 1.88 2, 188 0.16 a ¼ 0.11
b ¼ 0.20
c ¼ 0.26
.25 (0.51) 1.66 2, 188 0.19 a ¼ 0.16
b ¼ 0.10
c ¼ 0.23
.59 (0.61) 3.22 2, 189 0.04 a ¼ 0.31*
b ¼ 0.04
c ¼ 0.23
.80 (0.57) 2.69 2, 189 0.07 a ¼ 0.15
b ¼ 0.13
c ¼ 0.31*
7 (0.55) 7.44 2, 168 <0.01 a ¼ 0.49**
b ¼ 0.14
c ¼ 0.37*
3 (0.06) 5.71 2, 141 <0.01 a ¼ 0.48**
b ¼ 0.25
c ¼ 0.32*
us negative variation * p-value < 0.05, ** p-value < 0.01. P-values presented in bold
Table 3
Pearson correlations (two-tailed) of IQ, digit span, cognitive, event-related potential
(ERP), electroencephalogram (EEG) and actigraph measures with self-reported
symptoms and impairment in individuals with childhood ADHD (N ¼ 108).
ADHD symptoms Impairment
r p r p
IQ 0.12 0.21 0.02 0.81
Digit span forward 0.02 0.83 0.02 0.83
Digit span backward 0.07 0.45 0.01 0.92
RTV (CPT-OX) 0.23 0.02 0.02 0.82
RTV (Fast Task) 0.33 <0.01 0.21 0.03
Commission errors 0.01 0.94 0.04 0.70
Omission errors 0.24 0.01 0.18 0.07
CNV 0.18 0.07 0.06 0.53
Cue P3 0.14 0.15 ¡0.19 0.05
No Go P3 0.01 0.93 0.03 0.75
Delta 0.21 0.03 0.01 0.89
Theta 0.21 0.04 0.01 0.91
Alpha 0.19 0.04 0.14 0.16
Beta 0.09 0.37 0.09 0.35
Movement intensity 0.18 0.09 0.06 0.60
Movement count 0.26 0.03 0.18 0.15
RTV, reaction time variability; CE, commission errors; OE, omission errors; CNV,
continuous negative variation. Signiﬁcant values are presented in bold.
Table 4
Pearson correlations of IQ, digit span, cognitive, event-related potential (ERP),
electroencephalogram (EEG) and actigraph measures with self-reported symptoms
and clinical impairment in individuals with childhood ADHD (N ¼ 108); controlling
for IQ.
ADHD symptoms Impairment
r p r p
Digit span forward 0.07 0.49 0.03 0.76
Digit span backward 0.03 0.75 0.02 0.84
RTV (CPT-OX) 0.21 0.03 0.02 0.83
RTV (Fast Task) 0.31 <0.01 0.23 0.03
Commission errors 0.04 0.69 0.05 0.64
Omission errors 0.22 0.02 0.19 0.06
CNV 0.17 0.09 0.06 0.62
Cue P3 0.13 0.20 ¡0.20 0.05
No Go P3 <0.01 0.96 0.03 0.75
Delta 0.19 0.06 0.01 0.89
Theta 0.19 0.05 0.01 0.89
Alpha 0.19 0.05 0.14 0.16
Beta 0.09 0.35 0.09 0.35
Movement intensity 0.17 0.11 0.05 0.64
Movement count 0.26 0.04 0.17 0.19
RTV, reaction time variability; CE, commission errors; OE, omission errors; CNV,
continuous negative variation. Signiﬁcant values are presented in bold.
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toms (M ¼ 4.86, SD ¼ 0.23) was signiﬁcantly lower (t (107) ¼ 3.54,
p < 0.001) than parent-reported hyperactive-impulsive symptoms
(M ¼ 5.84, SD ¼ 0.25). Self-reported impairment was signiﬁcantly
lower (t (105) ¼ 4.67, p < 0.001) for self-report (M ¼ 11.01,
SD ¼ 5.73) than parent-report (M ¼ 13.91, SD ¼ 6.64). There was a
signiﬁcant correlation between self- and parent-reported ADHD
symptoms (r ¼ 0.37, p < 0.001), as well as impairments (r ¼ 0.48,
p < 0.001).
3.2. Which processes are impaired in the ADHD persistent group
based on self-report?
ADHD persistent-control group differences were observed on
all measures except for EEG delta, theta and beta activity, and
movement count (p > 0.05). After controlling for IQ, there were no
longer signiﬁcant ADHD persistent-control differences on DSF,
RTV (from CPT-OX) and alpha activity (Table 1). Controlling for IQ
led to slight reductions in effect sizes for most variables; however,
the effect size was still large for RTV from Fast Task (Table 1).
When we re-ran the analyses excluding females, the pattern of
ﬁndings did not change.
3.3. Which processes are impaired in the ADHD remittent group
deﬁned by self-report?
ADHD remittent-control group differences were observed on
the same measures that distinguished ADHD persisters from con-
trols, except for cue-P3. After controlling for IQ, ADHD remittent-
control group differences remained only for RTV (Fast Task), CE
and OE, and the effect sizes were reduced (Table 1).
When we re-ran the analyses with females removed a signiﬁ-
cant ADHD remittent-control difference in EEG beta activity
emerged, and there were no longer signiﬁcant differences on CNV
and DSF between remitters and controls (p > 0.05). The results did
not change for the remaining variables.
3.4. Which processes are markers of remission that distinguish
between ADHD persistent and remittent groups deﬁned by self-
report?
A marker of remission refers to a measure that distinguishes
ADHD remitters from persisters, but not from controls. In this
study, ADHD persisters and remitters only signiﬁcantly differed on
RTV (Fast Task). However, as the measure also distinguished ADHD
remitters from controls (p < 0.05) (Table 1), it does not fulﬁll the
criteria as a marker of remission but rather represents an inter-
mediate deﬁcit in ADHD remitters. After controlling for IQ, the
group ADHD persistent-remittent group difference remained sig-
niﬁcant for RTV (p < 0.001) and the effect size increased slightly
(from d’ ¼ 0.54 to d’ ¼ 0.61). The pattern of results did not change
when analyses excluded females.
3.5. How well do the objective data discriminate between ADHD
groups based on DSM-5 diagnostic symptom criterion?
When ADHD status was based on self-reports using the DSM-5
symptom criterion of 5 rather than 6 symptoms, three individuals
were re-classiﬁed as ADHD persisters, from being ADHD remitters
according to DSM-IV. The group-based analyses based on DSM-5
criteria showed the same results as when groups were based on
DSM-IV criteria, with the exceptions that signiﬁcant ADHD
remittent-control group differences emerged on the nogo-P3, in-
tensity movement count and beta activity, and there was no longera signiﬁcant ADHD persistent-control group difference on nogo-P3
(Table 2).
When ADHD groups were based on parent-reports using the
DSM-5 criterion, the same individuals were classiﬁed as ADHD
persisters and remitters as when DSM-IV criteria were used.3.6. Which objective measures are associated with the continuous
ratings of self-reported ADHD symptoms and impairments at follow
up in individuals with childhood ADHD?
Self-reported ADHD symptoms at follow up correlated signiﬁ-
cantly with RTV (CPT-OX & Fast Task), OE, delta, theta and alpha
activity and movement count. Self-reported ADHD impairment
correlated signiﬁcantly only with RTV (Fast Task) and cue-P3
amplitude (Table 3). After controlling for IQ, all signiﬁcant corre-
lations remained signiﬁcant, with only slight or no reduction in
coefﬁcient magnitudes (Table 4).
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self- and parent-report
The concordant ADHD group (meeting ADHD criteria according
to both informant reports) and discordant group (meeting ADHD
criteria according to parent report only) both signiﬁcantly differed
from controls and not from each other on: IQ and twelve objective
measures, including digit span (backward & forward), RTV (Fast
Task & CPT-OX), CE, OE, No-go P3, CNV, alpha activity and move-
ment intensity (Table 5). The pattern of results remained the same
after controlling for IQ in that no measure signiﬁcantly differenti-
ated between the concordant and discordant groups. All groups
signiﬁcantly differed from each other on self- and parent-reported
functional impairment, with the concordant group showing the
highest levels of reported impairment and controls showing the
lowest levels of reported impairment.
4. Discussion
Our follow-up study of 108 adolescents and young adults with a
childhood ADHD diagnosis and 167 controls revealed that ADHD
persistence and remittance based on self-report is poorly differ-
entiated by the objective measures, as opposed to groups deﬁned
by parent-report (Cheung et al., 2015). Although individuals with
persistent ADHD showed impairments relative to controls on most
objective measures, the objective measures did not differentiate
well between ADHD persisters and remitters. Overall, individuals
with childhood ADHD rated their levels of symptoms and impair-
ments as less severe than parents, leading to markedly different
prevalence rates of ADHD depending on rater. These ﬁndings sug-
gest that: (1) adolescents and young adults with ADHD tend to
report their levels of symptoms and impairments as lower than
their parents; (2) prevalence rates vary markedly according to
informant source; and (3) adolescents and young adults’ reports of
ADHD outcome are not as well reﬂected by objective cognitive,
neurophysiological and movement measures as parent-reports.
Individuals with persistent ADHD showed signiﬁcant impair-
ments on nearly all objective measures, suggesting that ADHDTable 5
Comparison on objective measures and reports of impairments between ADHD concord
Controls (n ¼ 167) Con
Age 17.77 (2.20) 18.4
Male n (%) 127c 34
IQ 110.23 (12.15)b,c 97.3
DSF 10.46 (2.15)b,c 9.26
DSB 8.04 (2.61)b,c 5.98
RTV (CPT-OX) 79.05 (36.96)b,c 99.0
RTV (Fast Task) 3.76 (0.89)b,c 4.86
CE 0.86 (1.33)b,c 2.05
OE 0.60 (1.00)b,c 2.95
Cue P3 6.81 (0.44)b 6.52
No-go P3 7.17 (0.38)b,c 6.99
CNV 3.84 (1.86)b,c 2.
Delta 1.45 (0.43)c 1.59
Theta 0.25 (0.51)c 0.
Alpha 0.59 (0.61)b,c 0.
Beta 1.80 (0.57)c 1.
Actigraph intensity 0.77 (0.55)b,c 1.27
Actigraph count 0.03 (0.06)b 0.05
Parent-reported impairment 2.73 (3.32)b,c 17.4
Self-reported impairment 3.29 (3.14)b,c 15.5
Concordant group: meeting ADHD criteria according to both self- and parent-report.
Discordant group: meeting ADHD criteria according to parent-report only.
a Signiﬁcantly (p < 0.05) different from controls.
b Signiﬁcantly (p < 0.05) different from concordant ADHD group.
c Signiﬁcantly (p < 0.05) different from discordant ADHD group.persisters deﬁned by self-report show similar proﬁles to ADHD
persisters deﬁned by parent-report. However, individuals who re-
ported themselves as ADHD remittent showed similar proﬁles of
underlying impairments as individuals who reported themselves as
persistent. In contrast, when ADHD outcome was based on parent-
reports (Cheung et al., 2015), ADHD persisters were impaired on all
objective measures, while remitters did not differ from controls on
any measures. ADHD remitters based on parent-reports differed
from ADHD persisters but not controls on several measures, sug-
gesting that these were markers of remission. Thus, the objective
data was far better at distinguishing between persistent and
remittent groups when these were based on parent-report,
compared to self-report. These ﬁndings were similar when the
revised DSM-5 symptom criteria for ADHD were applied to classify
diagnostic status at follow-up. Furthermore, the concordant
(meeting ADHD criteria according to both informant reports) and
discordant (meeting ADHD criteria according to parent report only)
groups signiﬁcantly differed from controls on most measures and
did not differ from each other on any objective measure, suggesting
that self-reports of ADHD at follow-up added little value over and
above parent-report alone in the association of ADHD with the
objective measures studied.
The analyses on continuous measures of ADHD symptoms
revealed that self- and parent-reports showed similar patterns of
associations with the objective measures, suggesting a quantitative
difference between self- and parent-reported symptoms, as they
differed in mean severity. Self-reported impairment correlated
signiﬁcantly with fewer objective measures than parent-reported
impairment, suggesting a qualitative difference between the in-
formants despite the moderately strong correlation (r ¼ 0.48,
p < 0.001) between them. This suggests that individuals evaluate
their level of impairment based on other factors than their parents.
Further investigations into self-reported impairment and its cor-
relates would be beneﬁcial in order to understand on what basis
young individuals estimate their levels of impairment.
It is important to acknowledge that there were notable dis-
crepancies in results depending on which informant was used. The
ADHD persistence rate based on self-reports was almost half theant and discordant groups and controls.
cordant ADHD group (n ¼ 43) Discordant ADHD group (n ¼ 42)
(only parent-reported ADHD)
5 (2.90) 18.16 (3.23)
36a
5 (17.23)a 94.21 (12.96)a
(2.36)a 9.33 (1.65)a
(2.36)a 6.48 (2.45)a
2 (47.56)a 122.81 (63.26)a
(0.90)a 4.59 (0.77)a
(2.74)a 2.17 (2.47)a
(3.87)a 2.64 (4.36)a
(0.52)a 6.63 (0.56)
(0.51)a 6.94 (0.48)a
80 (1.87)a 2.81 (1.75)a
(0.54) 1.68 (0.56)a
14 (0.55) 0.02 (0.65)a
37 (0.64)a 0.33 (0.77)a
67 (0.66) 1.56 (0.54)a
(0.76)a 1.11 (0.72)a
(0.04)a 0.05 (0.04)
4 (4.97)a,c 15.26 (5.49)a,b
6 (4.46)a,c 8.08 (4.20)a,b
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several markers of remission were identiﬁed when ADHD status
was based on parent-reports (Cheung et al., 2015), no markers of
remission were identiﬁed using self-report. These discrepancies
highlight the need for researchers to acknowledge differences in
ﬁndings due to informant source used, which may explain in-
consistencies in the ADHD literature across studies using different
informants to measure ADHD.
Taken together with other research showing rater effects on
ADHD prevalence rate at follow-up (Barkley et al., 2002) and her-
itability estimates (Merwood et al., 2013), further research is
needed to clarify which rater is most valid. Based on the available
data we would argue that parent ratings continue to be important
in adolescence and young adulthood, as they appear to better
reﬂect objective measures of impairment, as well as measures such
as the heritability of ADHD. These ﬁndings may be particularly
pertinent to recent publications suggesting that ADHD persistence
rate in adults is very low (Agnew-Blais et al., 2016; Caye et al., 2016;
Mofﬁtt et al., 2015), as these are based on self reports.
A limitation of this study is the wide age range of the sample.
Although age was controlled for in the quantitative analyses and
there were no signiﬁcant group differences on age, it would be
important to investigate the validity of self- vs parent-report using
a narrower age group, in particular individuals in their transition
into young adulthood. Furthermore, only cases diagnosed with
ADHD combined type in childhood were included in the sample in
order to reduce heterogeneity in the sample. Thus, ﬁndingsmay not
generalize to other presentations of ADHD. Moreover, we
acknowledge that the term ‘remitters’, when based on self-reports,
does not necessarily reﬂect a group of individuals who have
remitted from self-reported ADHD, as self-reports were not ob-
tained in childhood. Furthermore, although we found that self-
report of ADHD outcome was not well reﬂected by objective mea-
sures, it is possible that self-report is better captured by other
measures not included in our study.
In summary, this is the ﬁrst study to suggest that self-report of
ADHD outcome in adolescents and young adults is not as well re-
ﬂected by cognitive-neurophysiological and movement data as
parent-report. Our ﬁndings also demonstrate that there can be
considerable inconsistencies in research ﬁndings based on the
informant source used, which is important for researchers to
acknowledge. For clinicians the ﬁndings suggest that during the
follow-up of children with ADHD, care should be taken to continue
to gather reports from multiple informants including parents.
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